NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for phase I trial


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from D. Christie et al provide new insights into pediatrics
2009 NOV 28 ... according to the principles of MRC Good Clinical Practice (GCP) Guidelines and CTRU Phase III Trial Standard Operating procedures."Christie and colleagues published ...
Subject: Pediatrics
Price: $3.00
*
Duke University details research in knee osteoarthritis
2009 NOV 24 ... and radiographic knee osteoarthritis of at least one knee was assessed by late-phase (99m)Technetium methylene disphosphonate bone scintigraph, fixed-flexion knee ... bone scintigraphy is a dynamic imaging modality that holds great promise as a clinical trial screening tool and outcome measure." Kraus and colleagues published their ...
Subject: Knee Osteoarthritis
Price: $3.00
*
FDA-approved drugs eliminate, prevent cervical cancer in mice
2009 NOV 29 ... studies, which should take one or two years to complete, could be followed quickly with phase-two or phase-three clinical trials. Early phase trials would not be necessary since the ... Cancer, Breast Carcinoma, Cancer Vaccines, Cervical Cancer, Cervical Carcinoma, Clinical Trial Research, Endocrinology, Estrogen, FDA, Gynecology, HPV, Hormones, Human Papillomavirus, ...
Subject: University of Wisconsin-Madison
Price: $3.00
*
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... Plumb, President and CEO of Inhibitex, Inc. "We continue to anticipate completing our Phase II clinical trial of FV-100 in shingles patients around the middle of next year, and ...
Subject: Inhibitex, Inc.
Price: $3.00
*
New findings from Canterbury Christ Church University in the area of experimental psychology published
2009 NOV 28 ... to a control group that had been trained on a pseudorandom ordering, during a test phase in which both groups experienced effectively the same trial order," researchers in ...
Subject: Experimental Psychology
Price: $3.00
*
New sclerosis research from University of Florence outlined
2009 NOV 24 ... limit patient evaluation and the use of potentially effective drugs in the earliest phase of SSc. Early SSc may be suspected on the basis of Raynaud's phenomenon, puffy fingers, ... Rheumatic Diseases (The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a ...
Subject: Sclerosis
Price: $3.00
*
November/December 2009 Annals of Family Medicine tip sheet
2009 NOV 29 ... The authors assert that health care in the United States is nearing the end of a phase of exploitation and conservation in which rapid growth, specialization and ... Controlled Trials Authors frequently change the outcomes of clinical trials between trial registration and publication without explanation or disclosure. Analyzing 110 randomized ...
Subject: American Academy of Family Physicians
Price: $3.00
*
Skyscanner Appoints Agencies for Pilot TV ad Campaign
2009 NOV 28 ... said Skyscanner's Commercial VP, Frank Skivington. "The aim is to air the first phase TV trial in Scotland in January, so we were looking for an exceptional team that could ...
Subject: Skyscanner
Price: $3.00
*
Sunesis to Present Nonclinical Voreloxin Combination Data at AACR-EORTC-NCI Conference
2009 NOV 23 ... demonstrated in samples from patients treated with voreloxin in the Company's ongoing Phase 2 clinical study of voreloxin in combination with cytarabine in relapsed or refractory ... Keywords: Sunesis Pharmaceuticals, Inc., Cancer, Oncology, Clinical Trial Research, Sunesis Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company, ...
Subject: Sunesis Pharmaceuticals, Inc.
Price: $3.00
*
To Heal Diabetic Foot Ulcers, a New Drug Harnesses Stem Cells Inside Us All
2009 NOV 23 ... as potentially painful surgical interventions." Currently in a 75-patient Phase II diabetic foot ulcer clinical trial being conducted at some of the nation's top ...
Subject: Ulcer
Price: $3.00
*
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
2009 NOV 23 ... events; all AEs resolved by the end of both studies. "The results from these two Phase II studies provide further basis for the continued development of TBR-652 for the ... development programs. We look forward to the results from our on-going proof of concept trial of TBR-652." These data were presented at the 12th European AIDS ...
Subject: Pharmacokinetics
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
2009 NOV 23 ... Louisiana. The presentations will include additional positive data from 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and ...
Subject: Trubion Pharmaceuticals, Inc.
Price: $3.00
*
U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
2009 NOV 23 ... genes to sensory nerves from application in the skin. Fink is directing a phase 1 human trial on the first such vector carrying the gene for human preproenkephalin in ...
Subject: Herpes Simplex
Price: $3.00
*
Unigene Announces Financial Results for Third Quarter 2009
2009 NOV 23 ... 30, 2008. Increases for both periods were due to the initiation of our oral calcitonin Phase III clinical trial. Net loss for the three months ended September 30, 2009 ...
Subject: Unigene Laboratories, Inc.
Price: $3.00
*
Viron to Present Data from Phase II Trial at American Heart Association Conference
2009 NOV 23 ... of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific ...
Subject: Viron Therapeutics Inc.
Price: $3.00
*
Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
2009 NOV 23 ... end organ protection. The presentation at Windhover will review topline data from our Phase 1 study of VTP-27999, which was initiated in September, as well as select preclinical ... Investing, Venture Capital, Blood Pressure, Cardiology, Cardiovascular, Clinical Trial Research, Clinical Trials, Hypertension, Metabolic Disease, Pharmaceutical Business, ...
Subject: Vitae Pharmaceuticals, Inc.
Price: $3.00
*
Washington Biotechnology & Biomedical Association's New "Healthcare Economics in WA" Breaking News is Powered by MedIntelliBase(R) Intelligence Services
2009 NOV 24 ... Business · Competitive · Market Intelligence:Knowledge=>Insight=>Advantage The Next Phase, MedIntelliBase, A Better Way, and MarketTracks are trademarks of The Next Phase ... life sciences community. To learn more, visit washbio.org.Get a free 3-week trial of MedIntelliBase Alerts and Breaking News!Visit MedIntelliBase.com, contact us or ...
Subject: The Next Phase Consultancy, Inc.
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
2009 NOV 23 ... programs have progressed well. The palifosfamide (ZymafosTM, ZIO-201) randomized Phase II trial in metastatic or unresectable soft tissue sarcoma achieved the study-specified ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login